U.S. markets open in 4 hours
  • S&P Futures

    4,078.75
    -2.50 (-0.06%)
     
  • Dow Futures

    34,546.00
    -53.00 (-0.15%)
     
  • Nasdaq Futures

    12,021.25
    -21.00 (-0.17%)
     
  • Russell 2000 Futures

    1,891.10
    +3.60 (+0.19%)
     
  • Crude Oil

    80.97
    +0.42 (+0.52%)
     
  • Gold

    1,776.10
    +30.10 (+1.72%)
     
  • Silver

    22.31
    +0.52 (+2.41%)
     
  • EUR/USD

    1.0446
    +0.0038 (+0.37%)
     
  • 10-Yr Bond

    3.7030
    0.0000 (0.00%)
     
  • Vix

    20.90
    -0.99 (-4.52%)
     
  • GBP/USD

    1.2144
    +0.0082 (+0.68%)
     
  • USD/JPY

    136.4160
    -1.6640 (-1.21%)
     
  • BTC-USD

    17,100.84
    +210.95 (+1.25%)
     
  • CMC Crypto 200

    405.08
    +4.39 (+1.09%)
     
  • FTSE 100

    7,578.59
    +5.54 (+0.07%)
     
  • Nikkei 225

    28,226.08
    +257.09 (+0.92%)
     

InMode to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1-on-1 Conference

YOKNEAM, Israel, Aug. 8, 2022 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, today announced that senior management including Moshe Mizrahy, Chairman and Chief Executive Officer and Yair Malca, Chief Financial Officer, will participate at the 7th Annual Needham Virtual Med Tech & Diagnostics one-on-one Conference on Tuesday, Aug. 16, 2022.

InMode Ltd. Logo
InMode Ltd. Logo

 

The company will hold one-on-one investor meetings that same day. To schedule a meeting, please contact your Needham representative.

For more information about the event, visit InMode's investor relations site here.

About InMode 

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

 

Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
917-607-8654

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/inmode-to-participate-at-the-7th-annual-needham-virtual-med-tech--diagnostics-1-on-1-conference-301601405.html

SOURCE InMode Ltd.